A Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite ®

Condition:   Schizophrenia Intervention:   Combination Product: ABILIFY MYCITE Sponsor:   Otsuka Pharmaceutical Development& Commercialization, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials